ALNY

ALNYLAM PHARMACEUTICALS INC

ALNY·02043Q107·US·Common Stock·Healthcare - Biotechnology-13D/G

ALNY (ALNYLAM PHARMACEUTICALS INC) is held by 285 institutional investors as of Q2 2026. Largest holders: FMR LLC ($4.5B), Capital World Investors ($3.4B), BlackRock, Inc. ($3.3B). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 150 funds bought ALNY.

285
Holders
(23 Elite)
$36.4B
Total Value
52% (290)
Consensus
150 buying - 140 selling
13F: Insider & Congress: Updated regularly
ALNY

Smart Money Verdict

View all
Loading verdict
Held by 285 funds
23 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Apr 7, 2026 · Activists May 14, 2026 · Congress Jun 22, 2025

ActivistCapital World InvestorsCapital World Investors8.2%May 14, 2026
ActivistCapital Research Global InvestorsCapital Research Global Investors7.1%May 14, 2026
InsiderMMMcLaughlin MelissaSell $18KApr 6, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
15M(+3.0%)$4.5B0.2%-7.31%
39
Increased
11.1M(+3.2%)$3.4B0.4%+18.98%
39
Increased
10.9M(+4.4%)$3.3B0.0%-4.92%
33
Increased
9.8M(+3.0%)$2.9B0.4%-9.85%
39
Increased
6.5M(+0.7%)$2B0.1%-28.29%
32
Increased
6M(+1.4%)$1.8B0.0%-28.25%
32
Decreased
3.8M(-7.9%)$1.1B0.1%-35.49%
0
Increased
3.6M(+7.0%)$1.1B0.0%+10.58%
34
Decreased
2.6M(-0.9%)$791.3M0.0%+34.58%
0
Decreased
2.7M(-57.7%)$785.3M0.0%-38.72%
0
Decreased
2.4M(-2.2%)$734.5M0.7%+132.49%
0
Increased
2.1M(+9.0%)$635.3M0.1%-5.24%
41
Increased
2M(+48.9%)$598.3M2.1%-15.71%
74
Increased
2M(+1.4%)$588.6M0.3%+138.28%
38
Decreased
1.9M(-5.8%)$564.7M0.4%-29.92%
0
Increased
1.9M(+2.9%)$558.1M0.2%+13.82%
39
Decreased
1.3M(-7.1%)$379.1M0.3%-29.11%
0
Increased
1.1M(+4.3%)$332.4M0.2%-31.19%
39
Increased
1M(+2.9%)$310.7M0.0%-19.11%
32
Increased
994,476(+2.9%)$299.4M0.0%-22.78%
32

Showing 1-20 of 303

1 / 16
ALNYALNYALNYLAM PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used